Insider Selling: Microbix Biosystems Inc. (TSE:MBX) Director Sells 220,000 Shares of Stock

Microbix Biosystems Inc. (TSE:MBX - Get Free Report) Director Cameron Lionel Groome sold 220,000 shares of the business's stock in a transaction on Wednesday, October 9th. The shares were sold at an average price of C$0.33, for a total transaction of C$72,776.00.

Microbix Biosystems Price Performance

Shares of TSE:MBX opened at C$0.34 on Friday. The company's fifty day moving average is C$0.35 and its two-hundred day moving average is C$0.34. The company has a quick ratio of 5.57, a current ratio of 6.62 and a debt-to-equity ratio of 22.68. Microbix Biosystems Inc. has a 12-month low of C$0.23 and a 12-month high of C$0.45. The company has a market cap of C$46.48 million, a P/E ratio of 8.50 and a beta of 0.37.

About Microbix Biosystems

(Get Free Report)

Microbix Biosystems Inc, a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products.

See Also

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].

Insider Buying or Selling at Microbix Biosystems?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Microbix Biosystems and related companies.
Free Insider Buying and Selling Newsletter
Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report.
From Our Partners

Most Read This Month

Recent Articles